Skip to content

Clinical trials

Phase 3 Colitis, Ulcerative trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colitis, Ulcerative Phase: Phase 3 Country / region: Norway Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20142
20161
20171
20181
20212
20231
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Active, not recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC3
AbbVie2
Hoffmann-La Roche2
Abbott1
Alfasigma S.p.A.1
Eli Lilly and Company1
Ferring Pharmaceuticals1
Gilead Sciences1
InDex Pharmaceuticals1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colitis, Ulcerative14
Inflammatory Bowel Diseases3
Crohn Disease2
Arthritis, Juvenile1
Arthritis, Psoriatic1
Gastrointestinal Diseases1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.